The FDA has granted an in-person Type C meeting during the first quarter of 2026 New independent analyses across large observational ALS cohorts ...

Objective: To understand patient portal engagement stratified by patient characteristics among adults 50 years and older with at least 1 common chronic medical condition using electronic health ...

A systematic review of Long COVID identifies symptom clusters, highlighting fatigue and proposing a management framework for ...

Medicus Pharma Ltd. (Nasdaq: MDCX) is a precision guided biotech/life sciences company focused on accelerating the clinical development programs of novel and potentially disruptive therapeutics assets ...

Researchers identify specific psychosocial factors that strongly correlate with altered brain development within the first ...

Study shows alpha brain wave frequency shapes how the brain integrates touch and vision to create the feeling that your body ...

For patients with primary solid tumors receiving cancer therapy, clonal hematopoiesis of indeterminate potential is associated with an increased risk for CVD.

Powermax Minerals Inc. (CSE: PMAX) (“Powermax” or the “Company”) is pleased to announce interpretation results of a high-resolution ...

Over 70 percent of patients in the first-line subgroup responded to amivantamab plus chemotherapy with most responses lasting beyond 16 months Notable responses were ...

Artificial intelligence (AI) is increasingly used to analyze medical images, materials data and scientific measurements, but ...

DelveInsight's Persistent Corneal Edema Market Insights report includes a comprehensive understanding of current treatment ...